Stay updated on Nivolumab Plus Ipilimumab Regimens in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Plus Ipilimumab Regimens in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Plus Ipilimumab Regimens in Melanoma Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    Added related topics Melanoma and MedlinePlus Genetics, and updated revision from v3.4.3 to v3.5.0.
    Difference
    0.2%
    Check dated 2026-03-20T06:53:36.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    Removed Melanoma and the related topic MedlinePlus Genetics from the page's related topics.
    Difference
    0.1%
    Check dated 2026-03-13T01:23:39.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3 on the page.
    Difference
    0.0%
    Check dated 2026-03-05T19:45:35.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    Melanoma is added as a topic and MedlinePlus Genetics is listed as related topics. The page revision updated from v3.4.1 to v3.4.2.
    Difference
    0.2%
    Check dated 2026-02-12T02:09:22.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Minor revision update from v3.4.0 to v3.4.1; no changes to study content, data, or page functionality are evident. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-04T23:01:19.000Z thumbnail image
  8. Check
    69 days ago
    Change Detected
    Summary
    Added a glossary toggle and new metadata fields (Last Update Submitted that Met QC Criteria, No FEAR Act Data) with Revision: v3.4.0. Removed older/duplicate metadata terms (Last Update Submitted that met QC Criteria, No FEAR Act data) and related references (e.g., MedlinePlus Genetics).
    Difference
    0.3%
    Check dated 2026-01-28T21:44:02.000Z thumbnail image

Stay in the know with updates to Nivolumab Plus Ipilimumab Regimens in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus Ipilimumab Regimens in Melanoma Clinical Trial page.